Arbutus Biopharma Corp
NASDAQ:ABUS
Arbutus Biopharma Corp
NASDAQ:ABUS
Price:
3.84
USD
4.63%
Market Closed
Market Cap:
$738.5m
Wall Street
Price Targets
ABUS Price Targets Summary
Arbutus Biopharma Corp
Arbutus Biopharma Corp
Wall Street analysts forecast ABUS stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
ABUS
is 5.78 USD
with a low forecast of 5.05 USD and a high forecast of 7.35 USD.
Lowest
Price Target
5.05
USD
32% Upside
Average
Price Target
5.78
USD
51% Upside
Highest
Price Target
7.35
USD
91% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ABUS's stock price target?
Price Target
5.78
USD
5.78
USD
According to Wall Street analysts, the average 1-year price target for
ABUS
is 5.78 USD
with a low forecast of 5.05 USD and a high forecast of 7.35 USD.
What is Arbutus Biopharma Corp's Revenue forecast?
Projected CAGR
13%
13%
For the last 13 years the
compound annual growth rate for
Arbutus Biopharma Corp's revenue is
-7%.
The projected
CAGR
for the next 3 years is
13%.
